BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32433273)

  • 1. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria.
    Wilson B; Rossi M; Kanno T; Parkes GC; Anderson S; Mason AJ; Irving PM; Lomer MC; Whelan K
    Am J Gastroenterol; 2020 Jun; 115(6):906-915. PubMed ID: 32433273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
    Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome.
    Wilson B; Kanno T; Slater R; Rossi M; Irving PM; Lomer MC; Probert C; Mason AJ; Whelan K
    Aliment Pharmacol Ther; 2023 Aug; 58(4):404-416. PubMed ID: 37313992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
    Staudacher HM; Whelan K
    Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial.
    Goyal O; Batta S; Nohria S; Kishore H; Goyal P; Sehgal R; Sood A
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2107-2115. PubMed ID: 33464683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K
    Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes.
    Zhang Y; Feng L; Wang X; Fox M; Luo L; Du L; Chen B; Chen X; He H; Zhu S; Hu Z; Chen S; Long Y; Zhu Y; Xu L; Deng Y; Misselwitz B; Lang BM; Yilmaz B; Kim JJ; Owyang C; Dai N
    Am J Clin Nutr; 2021 Jun; 113(6):1531-1545. PubMed ID: 33740048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Schumann D; Klose P; Lauche R; Dobos G; Langhorst J; Cramer H
    Nutrition; 2018 Jan; 45():24-31. PubMed ID: 29129233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet.
    Valdez-Palomares F; Nambo-Venegas R; Uribe-García J; Mendoza-Vargas A; Granados-Portillo O; Meraz-Cruz N; Palacios-González B
    Food Funct; 2021 Apr; 12(7):3206-3218. PubMed ID: 33877245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.
    Wilson B; Whelan K
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():64-68. PubMed ID: 28244671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease.
    Pedersen N; Ankersen DV; Felding M; Wachmann H; Végh Z; Molzen L; Burisch J; Andersen JR; Munkholm P
    World J Gastroenterol; 2017 May; 23(18):3356-3366. PubMed ID: 28566897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome.
    Staudacher HM; Rossi M; Kaminski T; Dimidi E; Ralph FSE; Wilson B; Martin LD; Louis P; Lomer MCE; Irving PM; Whelan K
    Neurogastroenterol Motil; 2022 Apr; 34(4):e14241. PubMed ID: 34431172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
    Krumbeck JA; Rasmussen HE; Hutkins RW; Clarke J; Shawron K; Keshavarzian A; Walter J
    Microbiome; 2018 Jun; 6(1):121. PubMed ID: 29954454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.
    Hustoft TN; Hausken T; Ystad SO; Valeur J; Brokstad K; Hatlebakk JG; Lied GA
    Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27747984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better response to low FODMAP diet in disorders of gut-brain interaction patients with pronounced hydrogen response to a nutrient challenge test.
    Schindler V; Giezendanner S; Van Oudenhove L; Murray FR; Buehler J; Bordier V; Hente J; Pohl D
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3322-3328. PubMed ID: 34107550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.
    Ankersen DV; Weimers P; Bennedsen M; Haaber AB; Fjordside EL; Beber ME; Lieven C; Saboori S; Vad N; Rannem T; Marker D; Paridaens K; Frahm S; Jensen L; Rosager Hansen M; Burisch J; Munkholm P
    J Med Internet Res; 2021 Dec; 23(12):e30291. PubMed ID: 34904950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis.
    So D; Loughman A; Staudacher HM
    Am J Clin Nutr; 2022 Oct; 116(4):943-952. PubMed ID: 35728042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.
    Pedersen N; Andersen NN; Végh Z; Jensen L; Ankersen DV; Felding M; Simonsen MH; Burisch J; Munkholm P
    World J Gastroenterol; 2014 Nov; 20(43):16215-26. PubMed ID: 25473176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
    Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M
    World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.